1,898
Views
14
CrossRef citations to date
0
Altmetric
Editorial

Institutionalizing health technology assessment for priority setting and health policy in Latin America: from regional endeavors to national experiences

, , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Florian Dams, Javier Leonardo Gonzalez Rodriguez, Kei Long Cheung, Ben F. M. Wijnen & Mickaël Hiligsmann. (2018) Relevance of barriers and facilitators in the use of health technology assessment in Colombia. Journal of Medical Economics 21:5, pages 510-517.
Read now

Articles from other publishers (13)

Julia Simões Corrêa Galendi, Carlos Antonio Caramori, Clarissa Lemmen, Dirk Müller & Stephanie Stock. (2021) Expectations for the Development of Health Technology Assessment in Brazil. International Journal of Environmental Research and Public Health 18:22, pages 11912.
Crossref
Mayara Nascimento de Vasconcelos, Lucilane Maria Sales da Silva, Maria Veraci Oliveira Queiroz, Thereza Maria Magalhães Moreira, George Jó Bezerra Sousa & Maria Lúcia Duarte Pereira. (2021) Avanços e desafios das políticas públicas de gestão das tecnologias em saúde nas américas: scoping review. Ciência, Cuidado e Saúde 20.
Crossref
Mario J. Olivera, Francisco Palencia-Sánchez & Martha Riaño-Casallas. (2021) The Cost of Lost Productivity Due to Premature Chagas Disease-Related Mortality: Lessons from Colombia (2010–2017). Tropical Medicine and Infectious Disease 6:1, pages 17.
Crossref
Jorge Tomas Insua. (2018) Principialismo, bioética personalista y principios de acción en medicina y en servicios de salud. Persona y Bioética 22:2, pages 223-246.
Crossref
Andrés Pichon-Riviere, Natalie C. Soto, Federico Ariel Augustovski, Sebastián García Martí & Laura Sampietro-Colom. (2018) HEALTH TECHNOLOGY ASSESSMENT FOR DECISION MAKING IN LATIN AMERICA: GOOD PRACTICE PRINCIPLES. International Journal of Technology Assessment in Health Care 34:3, pages 241-247.
Crossref
Andres Pichon-Riviere, Natalie Soto, Federico Augustovski & Laura Sampietro-Colom. (2018) STAKEHOLDER INVOLVEMENT IN THE HEALTH TECHNOLOGY ASSESSMENT PROCESS IN LATIN AMERICA. International Journal of Technology Assessment in Health Care 34:3, pages 248-253.
Crossref
Yot Teerawattananon, Karlena Luz, Chalarntorn Yothasmutra, Raoh-Fang Pwu, Jeonghoon Ahn, Asrul Akmal Shafie, Kalipso Chalkidou, Sripen Tantivess, Benjarin Santatiwongchai, Waranya Rattanavipapong & Saudamini Dabak. (2018) HISTORICAL DEVELOPMENT OF THE HTAsiaLINK NETWORK AND ITS KEY DETERMINANTS OF SUCCESS. International Journal of Technology Assessment in Health Care 34:3, pages 260-266.
Crossref
Diego Rosselli, Camila Quirland-Lazo, Marcell Csanádi, Eva María Ruiz de Castilla, Nelly Cisneros González, Julio Valdés, Cesar Abicalaffe, William Garzón, Giovanny Leon & Zoltán Kaló. (2017) HTA Implementation in Latin American Countries: Comparison of Current and Preferred Status. Value in Health Regional Issues 14, pages 20-27.
Crossref
Andrés Pichon-RiviereNatalie C Soto, Federico Ariel AugustovskiSebastián García MartíLaura Sampietro-Colom. (2017) Evaluación de tecnologías sanitarias para la toma de decisiones en Latinoamérica: principios de buenas prácticas. Revista Panamericana de Salud Pública 41, pages 1.
Crossref
Rossana Ruiz, Kathrin Strasser-Weippl, Diego Touya, Carmen Herrero Vincent, Abraham Hernandez-Blanquisett, Jessica St. Louis, Alexandra Bukowski & Paul E. Goss. (2017) Improving access to high-cost cancer drugs in Latin America: Much to be done. Cancer 123:8, pages 1313-1323.
Crossref
Kalipso Chalkidou. (2017) Comparative effectiveness research around the globe: a valuable tool for achieving and sustaining universal healthcare. Journal of Comparative Effectiveness Research 6:2, pages 89-93.
Crossref
Eleanor M. Perfetto, Elisabeth M. Oehrlein, Marc Boutin, Sarah Reid & Eric Gascho. (2017) Value to Whom? The Patient Voice in the Value Discussion. Value in Health 20:2, pages 286-291.
Crossref
Jack Dowie, Mette Kjer Kaltoft, Jesper Bo Nielsen & Glenn Salkeld. (2015) Caveat emptor NICE: biased use of cost-effectiveness is inefficient and inequitable. F1000Research 4, pages 1078.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.